Neuraptive Therapeutics, Inc.
PHILADELPHIA, PA · Founded 2017 · CIK 0001713836 · Medtech · Private
Novel therapeutics and medical devices for peripheral nerve injury repair
neuraptive.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $30M
- 4 Form D · Oct 2022
- 48 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 2 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2017201820192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $25,000 | |
| Private capital raised | Form D · SEC | $100,000 | |
| Private capital raised | Form D · SEC | $10,224,998 | |
| Private capital raised | Form D · SEC | $19,490,348 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1061 | Serimmune | — | $20M |
| 1062 | 34 Lives, PBC | — | — |
| 1063 | AKNA HEALTH LLC | — | — |
| 1064 | Neuraptive Therapeutics, Inc. | — | $30M |
| 1065 | Vivamed, Inc. | — | $3.1M |
| 1066 | Intelligent Fingerprinting Ltd | — | $23M |
| 1067 | Lumier Corp | — | $50K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gino DiSciulloDirector
- Ivan GergelDirector
- Randy HubbellDirector
- David JacksonDirector · Executive Officer
- Greg ParekhDirector
- David PierceDirector
- Robert RadieDirector · Executive Officer
- Evan TzanisExecutive Officer
Patents
- Device And Method Of Creating A Fluid Containment Field For Administering Therapeutics To A Nerveapplication
- Device And Method Of Creating A Fluid Containment Field For Administering Therapeutics To A Nervegranted
- Device And Method Of Creating A Fluid Containment Field For Administering Therapeutics To A Nervegranted
- Method Of Treating Nerve Injuriesapplication
- Method Of Treating Nerve Injuriesapplication
- Device And Method Of Creating An Isolated Fluid Containment Field For Administration Of Therapeutic Agents To A Nerveapplication
- Device And Method Of Creating An Isolated Fluid Containment Field For Administration Of Therapeutic Agents To A Nerveapplication
- Method Of Treating Nerve Injuriesapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.